-

Piper Sandler Strengthens Technology Investment Banking with the Additions of Rob Freiman and Kegan Greene

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the additions of Rob Freiman and Kegan Greene as managing directors on the technology investment banking team. Freiman and Greene will both focus on the financial technology sector.

“Rob and Kegan are well-respected and talented bankers that will be able to come in and make an immediate impact to our efforts in the financial technology sector. They bring a wealth of knowledge and relationships and will play a pivotal role in our continued efforts to provide world-class advisory services to our clients,” said Steven Schmidt, co-head of technology investment banking at Piper Sandler.

“We are actively building our technology franchise at Piper Sandler and we are very excited to welcome Rob and Kegan to the team. Rob and Kegan have worked together for years and have a long and successful track record of providing advisory services to fintech clients,” said Brian White, co-head of technology investment banking at Piper Sandler.

Prior to joining Piper Sandler, Freiman and Greene co-led the U.S. financial technology investment banking effort at Jefferies Financial Group Inc., where Freiman was head of payments investment banking and Greene was head of insurance technology investment banking. Both individuals bring with them decades of experience in the financial technology sector.

“We are thrilled to be joining Piper Sandler. We believe the firm has a tremendous opportunity in financial technology given the combined strength of their technology and financial services businesses,” said Freiman and Greene.

ABOUT PIPER SANDLER

Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; and in Hong Kong through Piper Sandler Hong Kong Limited, authorized and regulated by the Securities and Futures Commission. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.

Follow Piper Sandler: LinkedIn | Facebook | X

©2024. Since 1895. Piper Sandler Companies. 800 Nicollet Mall, Minneapolis, Minnesota 55402-7036

Contacts

Nick Lawler
Tel: 212 891-8954
nick.lawler@psc.com

Piper Sandler Companies

NYSE:PIPR

Release Versions
$Cashtags

Contacts

Nick Lawler
Tel: 212 891-8954
nick.lawler@psc.com

Social Media Profiles
More News From Piper Sandler Companies

Piper Sandler Strengthens Fixed Income Platform with the Addition of Distressed Debt and Special Asset Group

NEW YORK--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the additions of John Mori and Eric Friel as managing directors to lead a new group that will focus on distressed debt and special assets. Mori will be based in Greenwich and Friel will be in New York, both reporting to Michael Piper, head of fixed income at Piper Sandler. The distressed debt and special asset group will source and trade specialized credit products, including distr...

Piper Sandler Companies Reports First Quarter 2026 Results; Increases Quarterly Dividend to $0.20 Per Share

MINNEAPOLIS--(BUSINESS WIRE)--The complete earnings release can be found on the firm's website at pipersandler.com/earnings...

Piper Sandler Strengthens Healthcare Investment Banking Team with the Addition of Patrick McCormack

MINNEAPOLIS & SAN FRANCISCO--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Patrick McCormack, M.D. as a managing director in the healthcare investment banking group. McCormack will be based in San Francisco and focused on advising biopharma companies on mergers and acquisitions and capital-raising transactions. “We are excited to welcome Patrick to the healthcare investment banking team. His deep expertise advising bioph...
Back to Newsroom